CLINICAL TRIALS PROFILE FOR VARITHENA
✉ Email this page to a colleague
All Clinical Trials for VARITHENA
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT02054325 ↗ | Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins | Completed | Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 | 2012-09-01 | It will be done a randomized triple-blind study comparing 0,2% polidocanol versus 75% hypertonic glucose of sclerotherapy in lower limbs´ reticular veins. It will be included only adult women with reticular veins on the side of the thighs and mild venous insufficiency (CEAP 1). The primary endpoint will be efficacy, and secondary will be safety. |
| NCT02054325 ↗ | Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Treatment of Reticular Veins | Completed | UPECLIN HC FM Botucatu Unesp | Phase 4 | 2012-09-01 | It will be done a randomized triple-blind study comparing 0,2% polidocanol versus 75% hypertonic glucose of sclerotherapy in lower limbs´ reticular veins. It will be included only adult women with reticular veins on the side of the thighs and mild venous insufficiency (CEAP 1). The primary endpoint will be efficacy, and secondary will be safety. |
| NCT02462720 ↗ | COMFORT: A Multicenter, Open-label, Randomized, Crossover Study | Completed | Boston Scientific Corporation | Phase 4 | 2015-05-01 | The purpose of this study is to evaluate pain the patient experienced following treatment of varicose veins with Varithena® compared to radiofrequency ablation. |
| NCT02462720 ↗ | COMFORT: A Multicenter, Open-label, Randomized, Crossover Study | Completed | BTG International Inc. | Phase 4 | 2015-05-01 | The purpose of this study is to evaluate pain the patient experienced following treatment of varicose veins with Varithena® compared to radiofrequency ablation. |
| NCT02657252 ↗ | Polidocanol Versus Glucose Treatment of Telangiectasia Trial | Completed | Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 | 2015-01-01 | It will be done a randomized triple-blind study comparing 0,2% polidocanol versus 75% hypertonic glucose of sclerotherapy in lower limbs´ telangiectasis. It will be included only adult women with reticular veins on the side of the thighs and mild venous insufficiency (CEAP 1). The primary endpoint will be efficacy, and secondary will be safety. |
| NCT02657252 ↗ | Polidocanol Versus Glucose Treatment of Telangiectasia Trial | Completed | UPECLIN HC FM Botucatu Unesp | Phase 4 | 2015-01-01 | It will be done a randomized triple-blind study comparing 0,2% polidocanol versus 75% hypertonic glucose of sclerotherapy in lower limbs´ telangiectasis. It will be included only adult women with reticular veins on the side of the thighs and mild venous insufficiency (CEAP 1). The primary endpoint will be efficacy, and secondary will be safety. |
| NCT02988063 ↗ | Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs | Withdrawn | BTG International Inc. | Phase 4 | 2017-04-10 | This study evaluates the addition of polidocanol endovenous microfoam (PEM) to compression therapy to determine effectiveness in improving the healing of venous leg ulcers (VLUs) in adults with severe venous disease of the great saphenous vein (GSV). All participants will receive treatment with Varithena and compression therapy. The purpose of this study is to assess whether the use of PEM to correct superficial axial and varicose vein reflux is effective in improving healing of VLUs, over treatment with compression alone. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for VARITHENA
Condition Name
Clinical Trial Locations for VARITHENA
Trials by Country
Clinical Trial Progress for VARITHENA
Clinical Trial Phase
Clinical Trial Sponsors for VARITHENA
Sponsor Name
